NCT00021060
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +19 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
Clinical trial condition
Lung Neoplasms
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
4,211 public trials
1,007 recruiting studies
Lung Neoplasms trial results
NCT00020709
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +19 more
- Locations
-
- Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States
NCT00077350
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
NCT00824746
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Chonnam National University Hwasun Hospital Hwasun-gun, Jeollanam-do, South Korea
NCT01139619
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Gävle, Sweden
- Research Site Linköping, Sweden
- Research Site Luleå, Sweden
NCT00686465
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
- Locations
-
- Juravinski Cancer Centre Hamilton, Ontario, Canada
- London Health Sciences Centre London, Ontario, Canada
- Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT00550173
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barretos, Brazil
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ijuí, Brazil
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
NCT00457119
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Georgetown University/Lombardi Cancer Center StudyCoordinator:CRAD001C2114 Washington D.C., District of Columbia, United States
- LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans, Louisiana, United States
- U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office Dallas, Texas, United States
- MD Anderson Cancer Center/University of Texas Thoractic Head/Neck Med. Onc. Houston, Texas, United States
NCT00005842
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
- Locations
-
- Brooke Army Medical Center Fort Sam Houston, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States
NCT00265317
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Antioch, California, United States